Monday, March 23

Ambarella, Inc. Announces Third Quarter Fiscal Year 2026 Financial Results


Ambarella
Ambarella

SANTA CLARA, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) — Ambarella, Inc. (NASDAQ: AMBA), an edge AI semiconductor company, today announced financial results for its third quarter of fiscal year 2026 ended October 31, 2025.

  • Revenue for the third quarter of fiscal 2026 was $108.5 million, up 31.2% from $82.7 million in the same period in fiscal 2025. For the nine months ended October 31, 2025, revenue was $289.8 million, up 44.3% from $200.9 million for the nine months ended October 31, 2024.

  • Gross margin under U.S. generally accepted accounting principles (GAAP) for the third quarter of fiscal 2026 was 59.6%, compared with 60.6% for the same period in fiscal 2025. For the nine months ended October 31, 2025, GAAP gross margin was 59.5%, compared with 60.7% for the nine months ended October 31, 2024.

  • GAAP net loss for the third quarter of fiscal 2026 was $15.1 million, or loss per diluted ordinary share of $0.35, compared with GAAP net loss of $24.1 million, or loss per diluted ordinary share of $0.58, for the same period in fiscal 2025. GAAP net loss for the nine months ended October 31, 2025 was 59.4 million or loss per diluted ordinary share of $1.40. This compares with GAAP net loss of $96.9 million, or loss per diluted ordinary share of $2.36, for the nine months ended October 31, 2024.

Financial results on a non-GAAP basis for the third quarter of fiscal 2026 are as follows:

  • Gross margin on a non-GAAP basis for the third quarter of fiscal 2026 was 60.9%, compared with 62.6% for the same period in fiscal 2025. For the nine months ended October 31, 2025, non-GAAP gross margin was 61.1%, compared with 63.0% for the nine months ended October 31, 2024.

  • Non-GAAP net profit for the third quarter of fiscal 2026 was $11.9 million, or earnings per diluted ordinary share of $0.27.   This compares with non-GAAP net profit of $4.6 million, or earnings per diluted ordinary share of $0.11, for the same period in fiscal 2025. Non-GAAP net profit for the nine months ended October 31, 2025 was $21.3 million, or earnings per diluted ordinary share of $0.49. This compares with non-GAAP net loss of $11.6 million, or loss per diluted ordinary share of $0.28, for the nine months ended October 31, 2024.

Based on information available as of today, Ambarella is offering the following guidance for the fourth quarter of fiscal year 2026, ending January 31, 2026:

  • Revenue is expected to be between $97.0 million and $103.0 million.

  • Gross margin on a non-GAAP basis is expected to be between 59.0% and 60.5%.

  • Operating expenses on a non-GAAP basis are expected to be between $55.0 million and $58.0 million.

Ambarella reports gross margin, net income (loss) and earnings (losses) per share in accordance with GAAP and, additionally, on a non-GAAP basis. Non-GAAP financial information excludes the impact of stock-based compensation and acquisition-related costs adjusted for the associated tax impact, which includes the effect of any benefits or shortfalls recognized. A reconciliation of the GAAP to non-GAAP gross margin, net income (loss) and earnings (losses) per share for the periods presented, as well as a description of the items excluded from the non-GAAP calculations, is included in the financial statements portion of this press release.

Total cash, cash equivalents and marketable debt securities on hand at the end of the third quarter of fiscal 2026 was $295.3 million, compared with $261.2 million at the end of the prior quarter and $226.5 million at the end of the same quarter a year ago.

“We reported record quarterly revenue, above the high-end of our third quarter guidance, with edge AI revenue setting its sixth consecutive revenue record. Year-to-date, our free-cash-flow is 14.8% of revenue, reflecting the strong growth and operating efficiency, as well as our ability to sustain our edge AI R&D investment. Our new F2026 revenue growth guidance range of 36% to 38% is projected to represent an all-time fiscal year record for the company, versus our prior estimate of 31% to 35%,” said Fermi Wang, President & CEO. “These results are encouraging, but we are even more excited about the opportunity ahead of us due to the rising breadth of edge AI applications demanding our products, the outlook for robust new product cycles given the demand for higher performance edge AI SoCs, as well as a rising average selling price outlook.”

Quarterly Conference Call

Ambarella plans to hold a conference call at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time today with Fermi Wang, President and Chief Executive Officer, and John Young, Chief Financial Officer, to discuss the third quarter of fiscal year 2026 results. A live and archived webcast of the call will be available on Ambarella’s website at http://www.ambarella.com/ for up to 30 days after the call.

About Ambarella

Ambarella’s products are used in a wide variety of edge AI applications, including video security, advanced driver assistance systems (ADAS), electronic mirror, telematics, driver/cabin monitoring, autonomous driving, edge infrastructure, drones and other robotics applications. Ambarella’s low-power systems-on-chip (SoCs) offer high-resolution video compression, advanced image and radar processing, and powerful deep neural network processing to enable intelligent perception, sensor fusion, and planning. For more information, please visit www.ambarella.com.

“Safe harbor” statement under the Private Securities Litigation Reform Act of 1995

This press release contains forward-looking statements that are not historical facts and often can be identified by terms such as “outlook,” “projected,” “intends,” “will,” “estimates,” “anticipates,” “expects,” “believes,” “could,” “should,” or similar expressions, including the guidance for the fourth quarter of fiscal year 2026 ending January 31, 2026, and the comments of our CEO relating to our expectation of future revenue growth, including for the full year of fiscal 2026, our ability to sustain our edge AI R&D investment, the breadth of our opportunities in edge AI applications, our outlook for robust new product cycles, and the outlook for the average selling price of our products. The achievement or success of the matters covered by such forward-looking statements involves risks, uncertainties and assumptions. Our actual results could differ materially from those predicted or implied and reported results should not be considered as an indication of our future performance.

The risks and uncertainties referred to above include, but are not limited to, global economic and political conditions; changes in government policies, including possible trade tariffs and restrictions; revenue being generated from new customers or design wins, neither of which is assured; the commercial success of our customers’ products; our customers’ ability to manage their inventory requirements; our growth strategy; our ability to anticipate future market demands and future needs of our customers, particularly for AI inference applications; our ability to introduce, and to generate revenue from, new and enhanced solutions; our ability to develop, and to generate revenue from, new advanced technologies, such as computer vision, AI functionality and advanced networks, including vision-language models and GenAI; our ability to retain and expand customer relationships and to achieve design wins; the expansion of our current markets and our ability to successfully enter new markets and applications, such as edge infrastructure; anticipated trends and challenges, including competition, in the markets in which we operate; risks associated with global health conditions and associated risk mitigation measures; our ability to effectively manage growth; our ability to retain key employees; and the potential for intellectual property disputes or other litigation.

Further information on these and other factors that could affect our financial results is included in the company’s Annual Report on Form 10-K for our 2025 fiscal year, which is on file with the Securities and Exchange Commission. Additional information will also be set forth in the company’s quarterly reports on Form 10-Q, annual reports on Form 10-K and other filings the company makes with the Securities and Exchange Commission from time to time, copies of which may be obtained by visiting the Investor Relations portion of our web site at www.ambarella.com or the SEC’s web site at www.sec.gov. Undue reliance should not be placed on the forward-looking statements in this release, which are based on information available to us on the date hereof. The results we report in our Quarterly Report on Form 10-Q for the third fiscal quarter ended October 31, 2025 could differ from the preliminary results announced in this press release.

Ambarella assumes no obligation and does not intend to update the forward-looking statements made in this press release, except as required by law.

Non-GAAP Financial Measures

The company has provided in this release non-GAAP financial information, including non-GAAP gross margin, net income (loss), and earnings (losses) per share, as a supplement to the condensed consolidated financial statements, which are prepared in accordance with generally accepted accounting principles (“GAAP”). Management uses these non-GAAP financial measures internally in analyzing the company’s financial results to assess operational performance and liquidity. The company believes that both management and investors benefit from referring to these non-GAAP financial measures in assessing its performance and when planning, forecasting and analyzing future periods. Further, the company believes these non-GAAP financial measures are useful to investors because they allow for greater transparency with respect to key financial metrics that the company uses in making operating decisions and because the company believes that investors and analysts use them to help assess the health of its business and for comparison to other companies. Non-GAAP results are presented for supplemental informational purposes only for understanding the company’s operating results. The non-GAAP information should not be considered a substitute for financial information presented in accordance with GAAP, and may be different from non-GAAP measures used by other companies.

With respect to its financial results for the third quarter of fiscal year 2026, the company has provided below reconciliations of its non-GAAP financial measures to its most directly comparable GAAP financial measures. With respect to the company’s expectations for the fourth quarter of fiscal year 2026, a reconciliation of non-GAAP gross margin and non-GAAP operating expenses guidance to the closest corresponding GAAP measure is not available without unreasonable efforts on a forward-looking basis due to the high variability and low visibility with respect to the charges excluded from these non-GAAP measures. We expect the variability of the above charges to have a significant, and potentially unpredictable, impact on our future GAAP financial results.

AMBARELLA, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except share and per share data)

(unaudited)

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended October 31,

 

Nine Months Ended October 31,

 

 

 

2025

 

 

 

2024

 

 

 

2025

 

 

 

2024

 

 

 

 

 

 

Revenue

 

$

108,452

 

 

$

82,653

 

 

$

289,835

 

 

$

200,850

 

 

 

 

 

 

 

 

 

 

Cost of revenue

 

 

43,866

 

 

 

32,605

 

 

 

117,482

 

 

 

78,901

 

Gross profit

 

 

64,586

 

 

 

50,048

 

 

 

172,353

 

 

 

121,949

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

Research and development

 

 

61,451

 

 

 

58,389

 

 

 

180,004

 

 

 

169,286

 

Selling, general and administrative

 

 

19,383

 

 

 

17,169

 

 

 

56,444

 

 

 

53,905

 

 

 

 

 

 

 

 

 

 

Total operating expenses

 

 

80,834

 

 

 

75,558

 

 

 

236,448

 

 

 

223,191

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

 

(16,248

)

 

 

(25,510

)

 

 

(64,095

)

 

 

(101,242

)

 

 

 

 

 

 

 

 

 

Other income, net

 

 

2,074

 

 

 

2,091

 

 

 

6,496

 

 

 

6,507

 

 

 

 

 

 

 

 

 

 

Loss before income taxes

 

 

(14,174

)

 

 

(23,419

)

 

 

(57,599

)

 

 

(94,735

)

 

 

 

 

 

 

 

 

 

Provision for income taxes

 

 

933

 

 

 

652

 

 

 

1,831

 

 

 

2,157

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(15,107

)

 

$

(24,071

)

 

$

(59,430

)

 

$

(96,892

)

 

 

 

 

 

 

 

 

 

Net loss per share attributable to ordinary shareholders:

 

 

 

 

 

 

 

 

Basic

 

$

(0.35

)

 

$

(0.58

)

 

$

(1.40

)

 

$

(2.36

)

Diluted

 

$

(0.35

)

 

$

(0.58

)

 

$

(1.40

)

 

$

(2.36

)

Weighted-average shares used to compute net loss per share

 

 

 

 

 

 

 

attributable to ordinary shareholders:

 

 

 

 

 

 

 

 

Basic

 

 

42,866,916

 

 

 

41,479,459

 

 

 

42,544,622

 

 

 

41,128,068

 

Diluted

 

 

42,866,916

 

 

 

41,479,459

 

 

 

42,544,622

 

 

 

41,128,068

 

 

 

 

 

 

 

 

 

 

The following tables present details of stock-based compensation and acquisition-related costs included in each functional line item in the condensed consolidated statements of operations above:

 

Three Months Ended October 31,

 

Nine Months Ended October 31,

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

(unaudited, in thousands)

Stock-based compensation:

 

 

 

 

 

 

 

Cost of revenue

$

658

 

$

899

 

$

2,389

 

$

2,339

Research and development

 

16,776

 

 

18,637

 

 

51,333

 

 

54,653

Selling, general and administrative

 

8,307

 

 

7,311

 

 

23,337

 

 

23,503

 

 

 

 

 

 

 

 

Total stock-based compensation

$

25,741

 

$

26,847

 

$

77,059

 

$

80,495

 

 

 

 

 

 

 

 

 

Three Months Ended October 31,

 

Nine Months Ended October 31,

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

(unaudited, in thousands)

Acquisition-related costs:

 

 

 

 

 

 

 

Cost of revenue

$

757

 

$

757

 

$

2,271

 

$

2,271

Research and development

 

 

 

 

 

 

 

Selling, general and administrative

 

456

 

 

510

 

 

1,368

 

 

1,560

 

 

 

 

 

 

 

 

Total acquisition-related costs

$

1,213

 

$

1,267

 

$

3,639

 

$

3,831

 

 

 

 

 

 

 

 

The difference between GAAP and non-GAAP gross margin was 1.3% and 2.0%, or $1.4 million and $1.7 million, for the three months ended October 31, 2025 and October 31, 2024, respectively. The difference between GAAP and non-GAAP gross margin was 1.6% and 2.3%, or $4.7 million and $4.6 million, for the nine months ended October 31, 2025 and October 31, 2024, respectively. The differences were due to the effect of stock-based compensation and the amortization of acquisition-related costs.

AMBARELLA, INC.

RECONCILIATION OF GAAP TO NON-GAAP DILUTED EARNINGS (LOSSES) PER SHARE

(in thousands, except share and per share data)

 

 

 

 

 

 

 

 

 

Three Months Ended October 31,

 

Nine Months Ended October 31,

 

 

2025

 

 

 

2024

 

 

 

2025

 

 

 

2024

 

 

(unaudited)

GAAP net loss

$

(15,107

)

 

$

(24,071

)

 

$

(59,430

)

 

$

(96,892

)

 

 

 

 

 

 

 

 

Non-GAAP adjustments:

 

 

 

 

 

 

 

Stock-based compensation expense

 

25,741

 

 

 

26,847

 

 

 

77,059

 

 

 

80,495

 

Acquisition-related costs

 

1,213

 

 

 

1,267

 

 

 

3,639

 

 

 

3,831

 

Income tax effect

 

17

 

 

 

416

 

 

 

53

 

 

 

1,016

 

Non-GAAP net income (loss)

$

11,864

 

 

$

4,459

 

 

$

21,321

 

 

$

(11,550

)

 

 

 

 

 

 

 

 

GAAP – diluted weighted average shares

 

42,866,916

 

 

 

41,479,459

 

 

 

42,544,622

 

 

 

41,128,068

 

Non-GAAP – diluted weighted average shares

 

43,954,650

 

 

 

41,632,232

 

 

 

43,117,403

 

 

 

41,128,068

 

 

 

 

 

 

 

 

 

GAAP – diluted net loss per share

$

(0.35

)

 

$

(0.58

)

 

$

(1.40

)

 

$

(2.36

)

Non-GAAP adjustments:

 

 

 

 

 

 

 

Stock-based compensation expense

 

0.60

 

 

 

0.65

 

 

 

1.81

 

 

 

1.96

 

Acquisition-related costs

 

0.03

 

 

 

0.03

 

 

 

0.09

 

 

 

0.09

 

Income tax effect

 

0.00

 

 

 

0.01

 

 

 

0.00

 

 

 

0.03

 

Effect of Non-GAAP – diluted weighted average shares

 

(0.01

)

 

 

 

 

 

(0.01

)

 

 

 

Non-GAAP – diluted net income (loss) per share

$

0.27

 

 

$

0.11

 

 

$

0.49

 

 

$

(0.28

)

 

 

 

 

 

 

 

 

AMBARELLA, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(unaudited, in thousands)

 

 

 

 

 

 

October 31,

 

January 31,

 

 

 

2025

 

 

 

2025

 

 

 

 

 

 

 

ASSETS

 

 

 

 

Current assets:

 

 

 

 

Cash and cash equivalents

$

174,057

 

 

$

144,622

 

 

Marketable debt securities

 

121,241

 

 

 

105,643

 

 

Accounts receivable, net

 

42,227

 

 

 

29,767

 

 

Inventories

 

39,159

 

 

 

34,428

 

 

Restricted cash

 

442

 

 

 

7

 

 

Prepaid expenses and other current assets

 

6,541

 

 

 

6,084

 

 

Total current assets

 

383,667

 

 

 

320,551

 

 

 

 

 

 

 

Property and equipment, net

 

10,725

 

 

 

9,084

 

 

Intangible assets, net

 

37,954

 

 

 

47,279

 

 

Operating lease right-of-use assets, net

 

12,765

 

 

 

5,188

 

 

Goodwill

 

303,625

 

 

 

303,625

 

 

Other non-current assets

 

3,154

 

 

 

3,241

 

 

 

 

 

 

 

Total assets

$

751,890

 

 

$

688,968

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

Current liabilities:

 

 

 

 

Accounts payable

 

34,923

 

 

 

21,775

 

 

Accrued and other current liabilities

 

88,398

 

 

 

80,781

 

 

Operating lease liabilities, current

 

1,733

 

 

 

2,829

 

 

Income taxes payable

 

1,890

 

 

 

1,383

 

 

Deferred revenue, current

 

17,509

 

 

 

14,226

 

 

Total current liabilities

 

144,453

 

 

 

120,994

 

 

 

 

 

 

 

Operating lease liabilities, non-current

 

11,913

 

 

 

2,436

 

 

Other long-term liabilities

 

5,411

 

 

 

4,126

 

 

 

 

 

 

 

Total liabilities

 

161,777

 

 

 

127,556

 

 

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

Preference shares

 

 

 

 

 

 

Ordinary shares

 

19

 

 

 

19

 

 

Additional paid-in capital

 

901,047

 

 

 

813,683

 

 

Accumulated other comprehensive income (loss)

 

534

 

 

 

(233

)

 

Accumulated deficit

 

(311,487

)

 

 

(252,057

)

 

Total shareholders’ equity

 

590,113

 

 

 

561,412

 

 

 

 

 

 

 

Total liabilities and shareholders’ equity

$

751,890

 

 

$

688,968

 

 

 

 

 

 

 

Contact:

Louis Gerhardy
408.636.2310
lgerhardy@ambarella.com



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *